NasdaqCM - Nasdaq Real Time Price USD
Precision BioSciences, Inc. (DTIL)
5.32
+0.19
+(3.70%)
At close: April 22 at 4:00:02 PM EDT
5.22
-0.10
(-1.88%)
After hours: April 22 at 6:29:46 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 261,343 | 19 |
| Sales | 61,043 | 8 |
| Net Shares Purchased (Sold) | 200,300 | 27 |
| Total Insider Shares Held | 985.62k | -- |
| % Net Shares Purchased (Sold) | 25.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BUEHLER KEVIN Director | Purchase at price 4.67 per share. | Direct | 21,122 | Mar 26, 2025 |
| BROWN MELINDA Director | Purchase at price 4.75 per share. | Direct | 8,735 | Mar 26, 2025 |
| GERMANO GENO J Director | Purchase at price 5.30 per share. | Direct | 17,225 | Mar 25, 2025 |
| AMOROSO MICHAEL Chief Executive Officer | Sale at price 5.56 per share. | Direct | 5,360 | Mar 24, 2025 |
| AMOROSO MICHAEL Chief Executive Officer | -- | Direct | -- | Mar 21, 2025 |
| SMITH J JEFFERSON Officer | Sale at price 4.91 per share. | Direct | 756 | Mar 4, 2025 |
| SCIMECA DARIO JOSEPH General Counsel | Sale at price 4.91 per share. | Direct | 1,336 | Mar 4, 2025 |
| KELLY JOHN ALEXANDER Chief Financial Officer | -- | Direct | -- | Mar 3, 2025 |
| SMITH J JEFFERSON Officer | -- | Direct | -- | Mar 3, 2025 |
| SCIMECA DARIO JOSEPH General Counsel | -- | Direct | -- | Mar 3, 2025 |
| SMITH J JEFFERSON Officer | Sale at price 4.79 per share. | Direct | 49,275 | Jan 22, 2025 |
| SCIMECA DARIO JOSEPH General Counsel | Sale at price 4.79 per share. | Direct | 42,765 | Jan 22, 2025 |
| AMOROSO MICHAEL Chief Executive Officer | Sale at price 4.67 per share. | Direct | 172,033 | Jan 21, 2025 |
| KELLY JOHN ALEXANDER Chief Financial Officer | -- | Direct | -- | Jan 17, 2025 |
| SMITH J JEFFERSON Officer | -- | Direct | -- | Jan 17, 2025 |
| SCIMECA DARIO JOSEPH General Counsel | -- | Direct | -- | Jan 17, 2025 |
| AMOROSO MICHAEL Chief Executive Officer | -- | Direct | -- | Jan 17, 2025 |
| GERMANO GENO J Director | Purchase at price 4.49 per share. | Direct | 16,186 | Dec 30, 2024 |
| BUEHLER KEVIN Director | Purchase at price 4.88 per share. | Direct | 21,082 | Dec 27, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | Purchase at price 4.75 per share. | Direct | 10,037 | Dec 27, 2024 |
| BROWN MELINDA Director | Purchase at price 4.55 per share. | Direct | 13,723 | Dec 26, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | Purchase at price 6.76 per share. | Direct | 20,280 | Nov 21, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | Sale at price 8.19 per share. | Direct | 4,816 | Nov 4, 2024 |
| AMOROSO MICHAEL Chief Executive Officer | Sale at price 8.19 per share. | Direct | 24,668 | Nov 4, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | -- | Direct | -- | Nov 1, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | -- | Direct | -- | Nov 1, 2024 |
| AMOROSO MICHAEL Chief Executive Officer | -- | Direct | -- | Nov 1, 2024 |
| SMITH J JEFFERSON Officer | Sale at price 11.79 per share. | Direct | 590 | Jun 10, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | Sale at price 11.79 per share. | Direct | 1,096 | Jun 10, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | -- | Direct | -- | Jun 7, 2024 |
| SMITH J JEFFERSON Officer | -- | Direct | -- | Jun 7, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | -- | Direct | -- | Jun 7, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | Stock Award(Grant) at price 12.00 per share. | Direct | 100,008 | May 8, 2024 |
| SMITH J JEFFERSON Officer | Stock Award(Grant) at price 12.00 per share. | Direct | 9,996 | May 8, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | Stock Award(Grant) at price 12.00 per share. | Direct | 9,996 | May 8, 2024 |
| AMOROSO MICHAEL Chief Executive Officer | Stock Award(Grant) at price 12.00 per share. | Direct | 100,008 | May 8, 2024 |
| BUEHLER KEVIN Director | -- | Direct | -- | May 3, 2024 |
| GERMANO GENO J Director | -- | Direct | -- | May 3, 2024 |
| WADSWORTH SAMUEL C Director | -- | Direct | -- | May 3, 2024 |
| BROWN MELINDA Director | -- | Direct | -- | May 3, 2024 |
| FRANKEL STANLEY R. Director | -- | Direct | -- | May 3, 2024 |
| PIRE SHARI LISA J.D. Director | -- | Direct | -- | May 3, 2024 |
| SMITH J JEFFERSON Officer | Sale at price 10.32 per share. | Direct | 1,589 | May 2, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | Sale at price 10.32 per share. | Direct | 2,807 | May 2, 2024 |
| AMOROSO MICHAEL Chief Executive Officer | Sale at price 10.32 per share. | Direct | 15,748 | May 2, 2024 |
| LIST ALAN FRANCIS Officer | Sale at price 10.32 per share. | Direct | 2,993 | May 2, 2024 |
| KELLY JOHN ALEXANDER Chief Financial Officer | -- | Direct | -- | May 1, 2024 |
| SMITH J JEFFERSON Officer | -- | Direct | -- | May 1, 2024 |
| SCIMECA DARIO JOSEPH General Counsel | -- | Direct | -- | May 1, 2024 |
| AMOROSO MICHAEL Chief Executive Officer | -- | Direct | -- | May 1, 2024 |
Related Tickers
MTVA MetaVia Inc.
0.7500
+1.35%
DWTX Dogwood Therapeutics, Inc.
5.46
+1.68%
SKYE Skye Bioscience, Inc.
1.5100
-3.82%
VERV Verve Therapeutics, Inc.
5.25
+9.83%
QURE uniQure N.V.
14.39
+8.28%
BCTX BriaCell Therapeutics Corp.
5.35
+27.68%
PSTV Plus Therapeutics, Inc.
0.7870
+22.78%
APVO Aptevo Therapeutics Inc.
0.6934
+9.08%
TGTX TG Therapeutics, Inc.
37.99
+2.76%
ACRV Acrivon Therapeutics, Inc.
2.0300
+6.28%